Cell Surface Marker Detection Market Analysis By Product (Flow Cytometry, Hematology Analyzers, Reagents & Kits), By Application (Disease Diagnosis & Identification, Research & Drug Discovery)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

According to Nova one advisor, the global Cell Surface Marker Detection market size was valued at USD 6.49 billion in 2022 and is predicted to hit USD 18.9 billion by 2030 with a registered CAGR of 9.2% during the forecast period 2022 to 2030.

This growth in demand can be attributed to rise in incidence of oncology diseases and other cell-associated disorders.  Rapid introduction of advancements and automations in clinical laboratories is a key factor affecting this industry. Incorporation of novel algorithms pertaining to diagnosis and prognosis of chronic disorders is expected to fuel demand of this market in the coming years. 

Requirement of solutions for data handling and interpretation of clinical conditions based on obtained results are anticipated to enhance potential for R&D in this sector, consequently driving market growth over the forecast period. 

The study found an increased rate of fungal co-infections in COVID-19 patients. The rate of secondary fungal infections increases in many COVID-19 patients due to their decreased immunity. Thus, the use of cell surface markers to study fungal infection is expected to boost the market’s growth. Such initiatives help drive a better understanding of the disease, leading to innovative ways to find a cure. More such research projects are being conducted worldwide, where cell surface markers are used to study the effect of COVID-19. Thus, such developments are expected to boost the market’s growth.

The major factors driving the market’s growth include the increasing demand for precision medicine, increased use of diagnostics, and technological advances related to increased throughput and automation. For example, over 200 cell-surface markers have been identified as being overexpressed in lung cancers, including cytokeratin fragment 21-1 and EGFR gene mutation. Diagnostic procedures are used to detect the presence of tumor cells in the blood through these markers. An increase in the number of cancer cases worldwide is expected to positively impact the demand for biomarkers, thus boosting the growth of the cell surface markers detection market. For instance, according to the Globocan 2020 report, the total number of breast cancer cases in 2020 was 2,261,419, followed by lung cancer cases (2,206,771) and prostate cancer cases (1,414,259). Thus, growing prevalence of the lung across across globe supports the market growth over the forecast period.

Precision medicine also known as personalized medicine, is the tailored medication given according to the individual patient’s characteristics. These medicines guides healthcare decisions towards a most effective treatment for an individual patient. Since cell surface markers serve as monograms to help identify and classify cells, the proteins expressed on the surface of cancerous cells serve as markers of specific tumor types. This molecule identification helps in disease diagnoses, finding direct treatment for the disease, and drug discovery, thus boosting the market’s growth. Many companies are involved in market preparation, which is likely to boost the market’s growth. For instance, Becton, Dickinson and Company manufactures the BD Lyoplate Human Cell Surface Marker Screening Panel for research laboratories. It can be used for screening primary cells or tissues and cell lines. It is compatible with flow cytometry and bioimaging technology platforms. Such innovative products with a wide variety of applications are expected to boost the market’s growth.

 Report Scope of the Cell Surface Marker Detection Market

Product Insights

Based on product segments the market includes flow cytometry, hematology analyzers, and reagents & kits. Flow cytometry accounts for the largest share of the market, owing to the benefits associated with the usage of the technique. These benefits include the provision of multi-parameter and quantitative analysis of lymphocytes, cell counting, and sorting simultaneously.

Moreover, the introduction of Fluorescence-Activated Cell Sorting (FACS) for rapid and quantitative individual sorting of varied biological cells on the basis of light scattering and fluorescent characteristics of an individual cell is projected to increase the usage and adoption rates of these techniques, thereby driving market growth.

The introduction of multiple lasers and fluorescent detectors to enhance quantification of cell parameters is expected to strengthen the scope of usage of these techniques in cytological research and other disease etiology-based studies, thereby influencing segment growth in future.

Applications Insights

Cell surface markers serve as the prime component in identification and classification of cells with similar characteristics. Applications for these techniques include disease diagnosis, diseases identification, research for drug discovery, and cytological academic research.

The increase in research incentives and grants for drug discovery and disease diagnosis in these applications are expected to generate considerable revenue to propel industrial growth till 2022. Clinical research on lymphocytes, which are known to express cell surface markers, has become a prominent and active area of research in immunology, thereby producing a significant potential for growth.

Characteristics associated with the use of cell surface markers such as quantification of novel drug targets for diseases and alteration in the pathophysiological mechanism are anticipated to attribute to their demand in R&D, thus, driving growth in future. Furthermore, disease diagnosis by application of this technology provides specific and early disease diagnosis, thus, leading to a consequent rise in research in this segment.

North America Dominates the Market and is Expected to Retain its Market Share During the Forecast Period

The North American region is the largest market for cell surface markers. Rapidly growing applications in disease diagnostics, the presence of well-established research institutions, and the biotech industry are the primary factors behind the large market size. The United States currently dominates the cell surface marker detection market in North America, and it is expected to continue its stronghold for a few more years. High healthcare expenditure, a high technological adaptation rate, and an increasing focus on precise and timely diagnostics are driving the market growth in the United States.

The United States has many companies operating in this sector, owing to which demand from the country is expected to be robust during the forecast period. Some US-based companies in the market include Nexcelom Bioscience LLC, Cofactor Genomics Inc., Abbott Laboratories, and Beckman Coulter Inc. The increased product launches by these players are expected to boost the market growth. For example, in November 2020, Bio-Rad Laboratories Inc., a US-based research and clinical diagnostic company, launched three StarBright Dyes specifically developed for flow cytometry. The dyes include StarBright Blue 700, StarBright Violet 440, and StarBright Violet 610, and they are fluorescent nanoparticles conjugated to Bio-Rad’s flow antibodies, providing maximal brightness and improved resolution. They can be used for detecting surface proteins in market detection. Additionally, in October 2020, Becton, Dickinson and Company announced that it received 510(k) clearance from the US FDA for BD FACSLyric Flow Cytometer with the integrated BD FACSDuet Sample Preparation System.Such initiatives by major players are likely to boost the market’s growth.

Some of the prominent players in the Cell Surface Marker Detection Market include:

·       Abbott Laboratories

·       Danaher Corporation (Beckman Coulter Inc.)

·       Becton, Dickinson and Company

·       Bio Rad Laboratories Inc.

·       F. Hoffmann-La Roche Ltd

·       Diasorin SpA (Luminex Corporation)

·       Nihon Kohden Corporation

·       Qiagen NV

·       Siemens Healthineers

·       Thermo Fisher Scientific Inc.

·       Grifols SA

·       Nexcelom Bioscience LLC

·       IVD Medical Holding Limited (Immucor Inc.)

·       Agilent Technologies Inc.

·       Sysmex Corporation

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Cell Surface Marker Detection market

Cell Surface Marker Detection Product

• Flow Cytometry
• Hematology Analyzers
• Reagents & Kits

Cell Surface Marker Detection Application

• Disease Diagnosis & Identification
• Research & Drug Discovery
• Others

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Cell Surface Marker Detection industry analysis from 2022 to 2030 to identify the prevailing Cell Surface Marker Detection industry opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the global Cell Surface Marker Detection industry segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global Cell Surface Marker Detection industry trends, key players, market segments, application areas, and market growth strategies.